Lamyra, established in 2011, operates as an international company with a global vision dedicated to advancing healthcare solutions.
The company’s mission is to develop and deliver innovative, accessible pharmaceuticals and medical products that promote health, prevent and manage diseases, and enhance longevity and well-being through cutting-edge scientific advancements.
Lamyra specializes in comprehensive research and development, manufacturing, and distribution of a wide range of therapeutic medications, biologically active supplements, medical devices, and cosmetic products. It also provides services for new product development and technology transfer, leveraging collaborations with leading laboratories worldwide. The company focuses on research, preclinical studies, and clinical trials as key areas of expertise.
With research centers located in the UAE, Belarus, Jordan, and Algeria, and manufacturing facilities in Great Britain, the UAE, Poland, and Belarus, Lamyra ensures all operations comply with the highest pharmaceutical industry standards, guaranteeing exceptional product quality.
The company’s product portfolio includes therapeutic drugs, vitamins, nutraceuticals, and medical devices. It prioritizes safety and efficacy, sourcing raw materials from globally renowned suppliers. A rigorous quality control system is implemented at every stage of production, ensuring compliance with international standards. All products are certified to meet regulatory requirements in the countries where they are officially available.
Lamyra remains committed to innovation and excellence, driving progress in the healthcare industry.